Cardiovascular Conditions

Epidemiology and Characteristics

Prinzmetal's angina affects approximately 0.5-1% of patients admitted to hospitals with angina, and episodes typically occur at rest, often during the night or early morning, demonstrating a waxing and waning pattern with periods of frequent daily episodes followed by symptom-free intervals, according to the European Heart Journal 1
The condition is characterized by episodes of transient acute myocardial ischemia due to coronary artery vasospasm, presenting with or without chest pain and associated with transient ST-segment elevation that resolves spontaneously or after nitroglycerin administration, although this fact is not directly cited, it is a fundamental aspect of the condition 1

The underlying mechanism of Prinzmetal's angina involves local hyperreactivity of coronary smooth muscle to various constrictor stimuli, including endothelium-derived factors, platelet-derived vasoactive substances, and variations in autonomic tone, as reported in the European Heart Journal 1

ECG monitoring during episodes and Holter recording can identify ischemic episodes without significant heart rate changes, suggesting primary reduction in oxygen supply, which is a crucial diagnostic approach, according to the European Heart Journal 1
Coronary angiography is recommended in patients with episodic chest pain accompanied by transient ST-segment elevation (Class I recommendation) according to the American College of Cardiology 2, 3, 4, 5
Documentation of ST-segment elevation during chest pain episodes that resolves when pain abates is crucial for diagnosis 3, 4, 5, 2
ECG monitoring during episodes of chest pain and exercise testing are recommended diagnostic tests 5, 2
Provocative testing may be considered in patients without documented ST-segment elevation during pain (Class IIb recommendation), but is contraindicated in patients with high-grade obstructive stenosis 5, 3, 2

The American College of Cardiology recommends high-dose calcium channel blockers as the cornerstone of treatment, with options including Verapamil 240-480 mg/day, Diltiazem 180-360 mg/day, or Nifedipine 60-120 mg/day 5, 6
If there is an inadequate response to initial therapy, a long-acting nitrate or a second calcium channel blocker from a different class may be added 5, 6
α-receptor blockers may benefit patients not responding completely to calcium channel blockers and nitrates 6
Nicorandil (potassium channel activator) may be useful in refractory cases 7
Beta-blockers have theoretical adverse potential and are generally contraindicated in Prinzmetal's angina 5
Short-acting nitroglycerin should be provided for acute symptom relief and situational prophylaxis, and long-acting nitrates may be added for prevention when calcium channel blockers alone are insufficient, with caution to avoid nitrate tolerance 7

Smoking cessation is critical as smoking is a major trigger for coronary vasospasm 3, 5, 2
Avoidance of triggers such as cold exposure, emotional stress, hyperventilation, alcohol consumption, and cocaine and amphetamine use is recommended 3, 5, 2
Risk factor modification, including smoking cessation, is essential 5, 3
Prognosis is generally excellent with appropriate medical therapy, especially in patients with normal or near-normal coronary arteries, with 5-year survival rates of 89-97% reported 5
Patients with coronary vasospasm superimposed on fixed obstructive CAD have a worse prognosis 5
Regular assessment of symptom frequency and severity, ECG monitoring during symptomatic episodes when possible, and adjustment of medication doses based on clinical response are essential for long-term management 3, 5, 7
Consider tapering and discontinuing treatment 6-12 months after angina has disappeared, as spontaneous remission occurs in about half of patients 7
Long-term follow-up is necessary due to the risk of serious complications including myocardial infarction, high-degree AV block, life-threatening ventricular arrhythmias, and sudden death 3, 5, 2
Percutaneous coronary intervention (PCI) may be considered in patients with chest pain, transient ST-segment elevation, and significant coronary artery stenosis (Class IIb recommendation) according to the American College of Cardiology 3, 4, 5, 2